Jazz Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell JAZZ and other ETFs, options, and stocks.

About JAZZ

Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. 

CEO
Bruce C. Cozadd
CEOBruce C. Cozadd
Employees
2,800
Employees2,800
Headquarters
Dublin, Dublin
HeadquartersDublin, Dublin
Founded
2005
Founded2005
Employees
2,800
Employees2,800

JAZZ Key Statistics

Market cap
6.94B
Market cap6.94B
Price-Earnings ratio
23.93
Price-Earnings ratio23.93
Dividend yield
Dividend yield
Average volume
614.93K
Average volume614.93K
High today
$111.55
High today$111.55
Low today
$104.50
Low today$104.50
Open price
$110.14
Open price$110.14
Volume
693.76K
Volume693.76K
52 Week high
$146.70
52 Week high$146.70
52 Week low
$103.01
52 Week low$103.01

JAZZ News

Yahoo Finance 1d
Jazz Pharmaceuticals First Quarter 2024 Earnings: Misses Expectations - Yahoo Finance

Jazz Pharmaceuticals (NASDAQ:JAZZ) First Quarter 2024 Results Key Financial Results Revenue: US$902.0m (up 1.0% from 1Q 2023). Net loss: US$14.6m (down by 12...

Jazz Pharmaceuticals First Quarter 2024 Earnings: Misses Expectations - Yahoo Finance
Benzinga 2d
Demystifying Jazz Pharmaceuticals: Insights From 15 Analyst Reviews - Jazz Pharmaceuticals - Benzinga

Loading... Loading... In the preceding three months, 15 analysts have released ratings for Jazz Pharmaceuticals JAZZ, presenting a wide array of perspectives f...

Demystifying Jazz Pharmaceuticals: Insights From 15 Analyst Reviews - Jazz Pharmaceuticals - Benzinga
TipRanks 3d
Jazz Pharmaceuticals reports Q1 non-GAAP EPS $2.68, consensus $4.18 - TipRanks.com - TipRanks

Reports Q1 revenue $901.98M, consensus $953.9M. “In Q1, we delivered combined double-digit year-over-year growth from our key growth drivers: Xywav, Epidiolex a...

Analyst ratings

80%

of 20 ratings
Buy
80%
Hold
20%
Sell
0%

More JAZZ News

Simply Wall St 4d
Based On Its ROE, Is Jazz Pharmaceuticals plc A High Quality Stock? - Simply Wall St

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like to learn about Return On Equity (ROE) and...

Based On Its ROE, Is Jazz Pharmaceuticals plc A High Quality Stock? - Simply Wall St
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.